Yield10 Bioscience, Inc. (YTEN)

Yield10 Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.6	1.07	2.36	5.33	3.42	5.42
Short-Term Investments	0	0	1.99	10.66	6.28	5.7
Cash & Cash Equivalents	1.6	1.07	4.35	15.99	9.7	11.12
Cash Growth	-11.72%	-75.43%	-72.81%	64.81%	-12.73%	92.70%
Receivables	0	0	0.03	0.2	0.11	0.09
Inventory	0	0	0	0	0	0
Other Current Assets	0.53	0.33	0.64	0.44	0.53	0.47
Total Current Assets	2.12	1.4	5.02	16.62	10.34	11.68
Property, Plant & Equipment	2.02	2.2	2.74	3.24	3.63	4.38
Long-Term Investments	0	0.26	0.26	0.26	0.26	0.33
Other Long-Term Assets	0.1	0.04	0.07	0.28	0.28	0.32
Total Long-Term Assets	2.12	2.51	3.07	3.79	4.18	5.03
Total Assets	4.24	3.91	8.09	20.42	14.52	16.72
Accounts Payable	1.65	1.2	0.11	0.08	0.06	0.28
Deferred Revenue	1.7	0	0	0	0	0
Current Debt	1.68	1.65	0.58	0.51	0.46	0.6
Other Current Liabilities	1.18	2.01	0.93	1.14	1.3	1.33
Total Current Liabilities	6.21	4.87	1.61	1.73	1.81	2.21
Long-Term Debt	1.35	1.53	2.08	2.65	3.16	3.62
Other Long-Term Liabilities	0	-0	0	0.01	0.01	14.98
Total Long-Term Liabilities	1.35	1.52	2.08	2.66	3.18	18.6
Total Liabilities	7.56	6.39	3.69	4.39	4.99	20.8
Total Debt	3.03	3.18	2.65	3.16	3.62	4.22
Debt Growth	20.50%	19.92%	-16.22%	-12.62%	-14.24%	-35.21%
Common Stock	0.01	0.12	0.05	0.05	0.03	0.01
Retained Earnings	-416.62	-414.15	-399.7	-386.13	-375.1	-364.89
Comprehensive Income	-0.26	-0.27	-0.23	-0.18	-0.16	-0.13
Shareholders' Equity	-3.31	-2.48	4.4	16.03	9.53	-4.09
Total Liabilities and Equity	4.24	3.91	8.09	20.42	14.52	16.72
Net Cash / Debt	-1.43	-2.11	1.7	12.83	6.08	6.9
Net Cash / Debt Growth	-	-	-86.77%	110.90%	-11.80%	-
Net Cash Per Share	-2.76	-6.37	8.29	65.06	61.51	453.48
Working Capital	-4.09	-3.47	3.41	14.89	8.53	9.48
Book Value Per Share	-6.39	-7.50	21.49	81.28	96.39	-268.63

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.